Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion type Assertion NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_head.
- NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion description "[In this first study applying new TFC to patients suspected of ARVD/C, 64% of probable ARVD/C patients and 11% of family members were additionally diagnosed. ECG criteria and pathogenic mutations especially contributed to new diagnosis. Newly proposed TFC ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_provenance.
- NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion evidence source_evidence_literature NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_provenance.
- NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion SIO_000772 20215590 NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_provenance.
- NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion wasDerivedFrom gad-20150221 NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_provenance.
- NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_assertion wasGeneratedBy ECO_0000203 NP167098.RAvY3TrXqzlxS0P0dbrwt3X9e84muByp6h6GEh7cP7P_c130_provenance.